Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Eye (Lond). 2009 Nov;23(11):2052-5. doi: 10.1038/eye.2008.424. Epub 2009 Jan 30.
To assess the efficacy of prismatic correction of residual esotropia <or=20 prism dioptres (PD) after full hypermetropic correction in patients with partially accommodative esotropia.
Medical records of 64 patients who received prismatic correction for residual esotropia </=20 PD were reviewed. Outcomes were considered successful if patients maintained orthotropia or esophoria for at least 1 year and did not require surgery. Factors including age, sex, visual acuity, refractive errors, amount of deviation, sensory status, and the presence of amblyopia were analysed and compared between the success and failure groups.
Prismatic correction was successful in 28 of 64 patients (44%). The success group showed better results both with Worth 4-dot test (P=0.001 at distance and P=0.046 at near) and Randot stereo test (P=0.003 for dots and P=0.000 for animals). Success rate increased to 58% without amblyopia, 72 and 93% with normal fusional response at near and at distance with Worth 4 dot test respectively, and 92% with stereoacuity of 800 s of arc or better. In all patients in success group, fusion and stereoacuity improved or maintained during follow-up.
Prismatic correction was successful in 44% of the patients with residual esotropia <or=20 PD and the success group showed an improved or stable sensory status with time. With a baseline fusion on Worth 4-dot test or stereopsis of 800 s of arc or better, prismatic correction could be considered as the first-line treatment.
评估棱镜矫正部分调节性内斜视患者远视全矫后残余内斜视<20 棱镜度(PD)的疗效。
回顾了 64 例接受棱镜矫正残余内斜视<20 PD 的患者的病历。如果患者至少 1 年保持正位或内隐斜视,且无需手术,则认为结果成功。分析并比较了成功组和失败组之间的年龄、性别、视力、屈光不正、斜视量、感觉状态和弱视等因素。
64 例患者中,28 例(44%)棱镜矫正成功。Worth 4 点测试(远距 P=0.001,近距 P=0.046)和 Randot 立体测试(点 P=0.003,动物 P=0.000)结果均显示成功组的结果更好。无弱视患者的成功率为 58%,Worth 4 点测试近距和远距正常融合反应的成功率分别为 72%和 93%,立体视锐度为 800 秒或更好的成功率为 92%。在所有成功组患者中,融合和立体视锐度在随访期间均有所改善或保持。
棱镜矫正可成功治疗 44%残余内斜视<20 PD 的患者,且随时间推移,成功组的感觉状态得到改善或保持稳定。如果基线 Worth 4 点测试融合或 800 秒立体视锐度更好,棱镜矫正可作为一线治疗。